Terns Pharmaceuticals, Inc. (TERN)
52.88
+2.88
(+5.76%)
USD |
NASDAQ |
Mar 25, 16:00
53.09
+0.21
(+0.40%)
After-Hours: 20:00
Terns Pharmaceuticals Cash from Investing (Quarterly) : 24.50M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | -322.77M |
| BioMarin Pharmaceutical, Inc. | -42.45M |
| ADMA Biologics, Inc. | -0.276M |
| Arcellx, Inc. | 57.80M |
| Corcept Therapeutics, Inc. | -11.84M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -19.77M |
| Free Cash Flow | -77.99M |
| Free Cash Flow Per Share (Quarterly) | -0.2156 |
| Free Cash Flow to Equity (Quarterly) | -19.67M |
| Free Cash Flow to Firm (Quarterly) | -19.77M |
| Free Cash Flow Yield | -1.61% |